Welcome to our dedicated page for Kopin SEC filings (Ticker: KOPN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Kopin Corporation (NASDAQ: KOPN) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures, including registration statements, current reports and financial reports filed with the U.S. Securities and Exchange Commission. Kopin describes itself in these documents as a Delaware corporation, incorporated in 1984 and headquartered in Westborough, Massachusetts, focused on high-performance microdisplays and application-specific optical solutions for defense, enterprise, industrial, consumer and medical products.
Among the key filings, Kopin has submitted Form S-1 and S-1/A registration statements related to the resale of common stock issued in a private placement. These documents outline the terms of a PIPE financing, the number of shares registered for resale, the Nasdaq Capital Market listing under the symbol KOPN, and risk factor and business overview sections that describe its microdisplay portfolio, Application Specific Optical Solutions (ASOS), and global defense and industrial markets.
The company also files multiple Form 8-K current reports to disclose material events. Recent 8-Ks describe a $15 million strategic investment from Theon International Plc, including the issuance of Series A Convertible Preferred Stock and a 49% interest in Kopin Europe Ltd., agreements to co-develop military-grade displays and color MicroLED products, a $41 million private placement of common stock, litigation-related financing arrangements, and leadership and compensation changes. Another 8-K incorporates by reference quarterly financial results, which detail revenue by category (defense, industrial/enterprise, medical, research and development, and license and royalties), expenses and net income or loss.
On Stock Titan, these filings are updated in near real time from EDGAR and can be paired with AI-powered summaries that explain the significance of each document. Users can quickly understand how a new S-1, 8-K or other filing affects Kopin’s capital structure, strategic partnerships, litigation exposure or operating performance. Investors can also use the filings page to monitor developments related to preferred stock terms, registration rights agreements, licensing and collaboration agreements, and other contracts referenced in Kopin’s disclosures.
Kopin Corporation reported that Erich Manz joined the company as Chief Financial Officer on September 2, 2025. In connection with his appointment, Kopin entered into an Inducement Restricted Stock Award Agreement with Mr. Manz on September 4, 2025 and granted him 400,000 restricted shares of Kopin common stock as a material inducement to employment.
The award was approved in accordance with Nasdaq Listing Rule 5635(c)(4). The restricted shares vest in four equal installments of 25% each on December 10 of every year beginning in 2026, as long as Mr. Manz remains employed with the company on each vesting date.
Kopin Corporation filed an amended report describing a strategic investment and collaboration with Theon International totaling $15 million. Theon will buy 1,000 shares of Kopin’s new Series A Convertible Preferred Stock for
Separately, Theon will invest
Kopin Corporation announced a $15.0 million strategic investment from Theon International Plc to advance collaborative military product development. Theon will acquire a 49% interest in Kopin Europe Ltd. for $8.0 million and will purchase $7.0 million of Kopin Series A Convertible Preferred Stock.
The Series A Preferred converts at an initial fixed price of $3.00 per share and may be force-converted by Kopin if the common stock trades at $4.50 or higher for 10 Trading Days within a 30 consecutive Trading Day period. The Preferred carries a 4% annual base dividend payable in cash and stock. The Agreement includes licensing, development and funding arrangements for joint military products, plus an additional $8.0 million commitment for targeted development over five years. The $15.0 million investment is subject to standard closing conditions, including European government approval, and is expected to close in Kopin's fiscal third quarter. The company filed a related press release as Exhibit 99.1.
Kopin Corporation reported consolidated results for the three and six months ended June 28, 2025 showing continued revenue generation but ongoing losses and liquidity pressure. For the six months the company recorded $18.99 million of total revenue and a $8.28 million net loss; revenue declined versus the prior year period. Cash and cash equivalents were $24.37 million with $1.05 million of restricted cash, and combined cash, cash equivalents and restricted cash totaled $25.42 million at period end after significant sales of marketable securities.
Balance sheet and contingency items weigh on near-term prospects: marketable securities fell to $2.42 million from prior period levels, stockholders' equity was $16.04 million, and the company carries an accrued $24.8 million litigation damages amount. Management discloses substantial doubt about the company’s ability to continue as a going concern for twelve months and describes plans to reduce cash outflows and potentially raise capital. Defense end-market sales declined, while industrial and medical sales showed some increases; supply-chain risks for semiconductors remain a stated constraint.
Kopin Corporation filed a Current Report on Form 8-K disclosing that it issued a press release on August 12, 2025 announcing its financial results for the second quarter ended June 28, 2025. The 8-K references the press release as Exhibit 99.1 and embeds the cover page interactive XBRL as Exhibit 104. The filing itself does not present the financial figures within the body of the form; the press release is incorporated by reference.
The report is signed by Richard A. Sneider, Treasurer and Chief Financial Officer, and otherwise serves as a routine disclosure of the company's earnings announcement.
On 7 Aug 2025 Kopin Corporation (Nasdaq: KOPN) filed a Form 8-K to report the appointment of Mr. Erich Manz as Chief Financial Officer, effective 2 Sep 2025.
Mr. Manz joins after a 25-year career at Allegro MicroSystems where he most recently served as Business Unit CFO. His compensation package includes:
- $300,000 annual base salary
- 400,000 restricted shares vesting 25 % each 10 Dec beginning 2026
- Annual performance-based cash and long-term incentive opportunity
- Eligibility for the Company’s standard employee benefits
The Company issued a press release (Exhibit 99.1) announcing the leadership change. No other material events, financial results or transactions were disclosed.
FAQ
What is the current stock price of Kopin (KOPN)?
What is the market cap of Kopin (KOPN)?
